Skip to main content

Table 4 Association between PCSK9 E670G polymorphism and lipid levels

From: Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population

   TC (mmol/l) TG (mmol/l) HDL-C (mmol/l) LDL-C (mmol/l) Apo A1 (g/l) Apo B (g/l) AIP
CAD AA 4.59 ± 1.06 1.85 ± 1.53 1.08 ± 0.27 2.93 ± 0.93 1.18 ± 0.23 0.97 ± 0.30 0.15 ± 0.28
AG + GG 4.64 ± 0.94 1.77 ± 1.15 1.07 ± 0.22 3.01 ± 0.78 1.19 ± 0.21 0.99 ± 0.26 0.05 ± 0.24
P 0.565 0.876 0.798 0.462 0.574 0.457 0.339
Controls AA 4.41 ± 0.97 1.77 ± 1.51 1.16 ± 0.30 2.64 ± 0.80 1.23 ± 0.24 0.91 ± 0.26 0.09 ± 0.34
AG + GG 4.46 ± 0.90 1.63 ± 1.02 1.17 ± 0.34 2.67 ± 0.74 1.23 ± 0.24 0.90 ± 0.27 0.08 ± 0.36
P 0.831 0.482 0.823 0.822 0.929 0.912 0.937
  1. CAD coronary artery disease, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AIP atherogenic index of plasma